Captopril-associated neutropenia. Who is at risk?
The DOI matches its OpenAlex record.
Abstract
Captopril is a new drug effective both in the treatment of hypertension and in the management of refractory congestive heart failure. Neutropenia was observed early in the clinical testing of captopril,1-6causing the Food and Drug Administration to limit its use in the treatment of hypertension in severely affected patients. However, with added experience, it has become apparent that the risk of neutropenia is different among various patient groups. For patients with uncomplicated hypertension, neutropenia is infrequent and represents no greater a risk than exists with other commonly used drugs. In contrast, for patients with renal dysfunction, particularly those who also have a collagen-vascular disease, neutropenia is a risk that must be carefully balanced by potential therapeutic benefits. These conclusions are based on an analysis of all cases of captopril-associated neutropenia published or reported to the drug's manufacturer as of July 1982, and also on an assessment of more
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Angiotensin-Converting Enzyme Inhibitors
Brown, N. J., & Vaughan, D. E. (1998) · Circulation · doi:10.1161/01.cir.97.14.1411 · Cited by 958
Converting-Enzyme Inhibitors in the Treatment of Hypertension
Oates, J. A., Wood, A. J. J., & Williams, G. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812083192305 · Cited by 364
Brogden, R. N., Todd, P. A., & Sorkin, E. M. (1988) · Drugs · doi:10.2165/00003495-198836050-00003 · Cited by 318
Conn, V. S., Hafdahl, A. R., Cooper, P. S., Ruppar, T. M., Mehr, D. R., & Russell, C. L. (2009) · The Gerontologist · doi:10.1093/geront/gnp037 · Cited by 227
Metadata
- Authors
- Cooper, R. A.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association
- Published
- 1983-04-01
- Volume
- 143
- Issue
- 4
- Pages
- 659-660
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W4255652665
- Cited by
- 88
- References
- 0
- FWCI
- 6.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Captopril-associated neutropenia. Who is at risk? https://app.cochat.ai/papers/10.1001/archinte.143.4.659
- The paper
- Cooper, R. A. (1983). Captopril-associated neutropenia. Who is at risk? Archives of Internal Medicine. https://doi.org/10.1001/archinte.143.4.659
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.